LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Open

SectorHealthcare

32.77 2.34

Overview

Share price change

24h

Current

Min

32.02

Max

32.79

Key metrics

By Trading Economics

Income

13M

5.6M

Sales

21M

291M

P/E

Sector Avg

66.18

35.724

EPS

-0.151

Profit margin

1.941

Employees

3,650

EBITDA

42M

30M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+30.06% upside

Dividends

By Dow Jones

Next Earnings

29 paź 2025

Market Stats

By TradingEconomics

Market Cap

162M

1.5B

Previous open

30.43

Previous close

32.77

News Sentiment

By Acuity

50%

50%

167 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Omnicell Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2025, 23:07 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 wrz 2025, 22:10 UTC

Major Market Movers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 wrz 2025, 21:47 UTC

Earnings

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 wrz 2025, 16:52 UTC

Major Market Movers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 wrz 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 wrz 2025, 21:40 UTC

Acquisitions, Mergers, Takeovers

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 wrz 2025, 21:07 UTC

Earnings

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 wrz 2025, 21:07 UTC

Earnings

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Rev $17.35B >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q EPS 82c >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Net $782.5M >ATD.T

2 wrz 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2 wrz 2025, 20:53 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 wrz 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 wrz 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 wrz 2025, 20:27 UTC

Earnings

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 wrz 2025, 20:24 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 wrz 2025, 20:18 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 wrz 2025, 20:17 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 wrz 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 wrz 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 wrz 2025, 20:15 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 wrz 2025, 19:55 UTC

Earnings

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 wrz 2025, 19:50 UTC

Acquisitions, Mergers, Takeovers

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 wrz 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 wrz 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 wrz 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2 wrz 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 wrz 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Comparison

Price change

Omnicell Inc Forecast

Price Target

By TipRanks

30.06% upside

12 Months Forecast

Average 41.75 USD  30.06%

High 55 USD

Low 32 USD

Based on 6 Wall Street analysts offering 12 month price targets forOmnicell Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

24.23 / 30.44Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

167 / 371 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.